Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers - PubMed (original) (raw)
Comparative Study
doi: 10.1093/hmg/3.4.565.
Affiliations
- PMID: 8069299
- DOI: 10.1093/hmg/3.4.565
Comparative Study
Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers
H Arakawa et al. Hum Mol Genet. 1994 Apr.
Abstract
To investigate a potential role of NF2, the gene responsible for hereditary bilateral acoustic neurinomas, during carcinogenesis of non-neurogenic tissues, we screened somatic mutations of NF2 in 55 breast cancers and 44 colorectal carcinomas by an RNase protection assay coupled with the reverse-transcriptase polymerase chain reaction (RT-PCR). By screening the entire coding region of the gene in these tumors, we detected missense mutations in the exon encoding the alpha-helical domain of the NF2 product in two colorectal carcinomas. No mutations were detected in any of the breast cancers. Our results suggested that inactivation of the NF2 gene was associated with carcinogenesis in some, but not the majority of, colorectal tumors. In the course of these analyses, we found various alternatively-spliced forms of NF2 transcript. These variants showed no specificity among the tissues examined except for one that resulted from alternative splicing at the 3'-region; this form was more abundantly expressed in skeletal and cardiac muscles than in other tissues.
Similar articles
- The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts.
Pykett MJ, Murphy M, Harnish PR, George DL. Pykett MJ, et al. Hum Mol Genet. 1994 Apr;3(4):559-64. doi: 10.1093/hmg/3.4.559. Hum Mol Genet. 1994. PMID: 8069298 - Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias.
Yoo NJ, Park SW, Lee SH. Yoo NJ, et al. Pathology. 2012 Jan;44(1):29-32. doi: 10.1097/PAT.0b013e32834c3599. Pathology. 2012. PMID: 22081132 - Low incidence of a nucleotide sequence alteration of the neurofibromatosis 2 gene in human breast cancers.
Yaegashi S, Sachse R, Ohuchi N, Mori S, Sekiya T. Yaegashi S, et al. Jpn J Cancer Res. 1995 Oct;86(10):929-33. doi: 10.1111/j.1349-7006.1995.tb03003.x. Jpn J Cancer Res. 1995. PMID: 7493911 Free PMC article. - Neurofibromatosis 2 gene in human colorectal cancer.
Rustgi AK, Xu L, Pinney D, Sterner C, Beauchamp R, Schmidt S, Gusella JF, Ramesh V. Rustgi AK, et al. Cancer Genet Cytogenet. 1995 Oct 1;84(1):24-6. doi: 10.1016/0165-4608(95)00059-3. Cancer Genet Cytogenet. 1995. PMID: 7497438 - ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers.
Johnstone CN, Castellví-Bel S, Chang LM, Bessa X, Nakagawa H, Harada H, Sung RK, Piqué JM, Castells A, Rustgi AK. Johnstone CN, et al. Gene. 2004 Jul 7;336(1):59-71. doi: 10.1016/j.gene.2004.01.025. Gene. 2004. PMID: 15225876
Cited by
- High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.
Bianchi AB, Mitsunaga SI, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJ, Testa JR. Bianchi AB, et al. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10854-8. doi: 10.1073/pnas.92.24.10854. Proc Natl Acad Sci U S A. 1995. PMID: 7479897 Free PMC article. - Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions.
Ellis JR Jr, Heinrich B, Mautner VF, Kluwe L. Ellis JR Jr, et al. Genes Chromosomes Cancer. 2011 Aug;50(8):571-84. doi: 10.1002/gcc.20876. Epub 2011 May 11. Genes Chromosomes Cancer. 2011. PMID: 21563229 Free PMC article. - Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation.
Morrow KA, Das S, Metge BJ, Ye K, Mulekar MS, Tucker JA, Samant RS, Shevde LA. Morrow KA, et al. J Biol Chem. 2011 Nov 18;286(46):40376-85. doi: 10.1074/jbc.M111.250035. Epub 2011 Sep 30. J Biol Chem. 2011. PMID: 21965655 Free PMC article. - YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.
Szulzewsky F, Holland EC, Vasioukhin V. Szulzewsky F, et al. Dev Biol. 2021 Jul;475:205-221. doi: 10.1016/j.ydbio.2020.12.018. Epub 2021 Jan 8. Dev Biol. 2021. PMID: 33428889 Free PMC article. Review. - Mouse models of neurofibromatosis 1 and 2.
Gutmann DH, Giovannini M. Gutmann DH, et al. Neoplasia. 2002 Jul-Aug;4(4):279-90. doi: 10.1038/sj.neo.7900249. Neoplasia. 2002. PMID: 12082543 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous